Camzyos 2.5 mg
Camzyos 2.5 mg is a medicine authorised by Swissmedic under authorisation number 68477. The authorisation holder is Bristol-Myers Squibb SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 25 April 2023 and the authorisation is limited until 24 April 2028. ATC code C01EB24 places the medicine in the group Cardiac therapy.
| Authorisation number | 68477 |
|---|---|
| Name | Camzyos 2.5 mg |
| Full name | Camzyos 2.5 mg, Hartkapseln |
| Authorisation holder | Bristol-Myers Squibb SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C01EB24 |
| First authorisation | 25 April 2023 |
| Authorisation validity | 24 April 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Camzyos 2.5 mg, Hartkapseln | B | 25 April 2023 |
| 2 | Camzyos 5 mg, Hartkapseln | B | 25 April 2023 |
| 3 | Camzyos 10 mg, Hartkapseln | B | 25 April 2023 |
| 4 | Camzyos 15 mg, Hartkapseln | B | 25 April 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Kapsel(n) | C01EB24 | 02.99.0. | B |
| 3 | 28 | Kapsel(n) | C01EB24 | 02.99.0. | B |
| 4 | 28 | Kapsel(n) | C01EB24 | 02.99.0. | B |
| 5 | 28 | Kapsel(n) | C01EB24 | 02.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Camzyos 2.5 mg authorised in Switzerland?
Yes. Camzyos 2.5 mg is authorised by Swissmedic under authorisation number 68477, data as of 01 September 2026. The authorisation is limited until 24 April 2028.
Which dispensing category does Camzyos 2.5 mg have?
Camzyos 2.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Camzyos 2.5 mg?
The authorisation holder is Bristol-Myers Squibb SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.